Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03555877
Title Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer (AMICA)
Acronym AMICA
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors German Breast Group
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.